Nosocomial infections (NIs) are hospital-acquired associated infections, and also contracted due to the infections or toxins that exist in some location, like hospital. Therefore in our study, 4 Lactic acid bacteria (LAB) isolates were obtained from dairy product (Lactobacillus brevis, L. acidophilus, Lactococcus raffinolactis and Lactococcus lactis) and were tested for Bacteriocin production to select Lactococcus lactis among them. Cell free supernatant (CFS), Lipid and partial purification of protein La. Lactis had high inhibitory effect against test pathogens (E. coli, Bacillus cereus, Staphylococcus aureus and Streptococcus). 30 isolates that diagnosed by Vitec, were isolated from (3) hospitals in Baghdad/ Iraq. The results showed that the bacteriocin exhibited higher inhibition activity against the microorganisms (that isolated from hospitals), so we recommended that La. lactis is a good natural agent candidate that could be inhibitor to microorganism isolated from hospitals, so it is a good factor to decrease nosocomial infections.
